Diabetes
Diabetes mellitus is a major source of morbidity and economic expense within the United States. Among the most prevalent chronic diseases, 7.8 million persons were diagnosed with diabetes in 1994 -- this represents nearly three persons for every 100 non-institutionalized persons in the U.S. Additionally, the American Diabetes Association has estimated that a similar number of persons may have the disease unknowingly. Persons with diabetes are at risk for the development of specific acute metabolic complications, such as diabetic ketoacidosis, hyperglycemic hypersmolor nonketotic coma, and hypoglycemia, and a variety of chronic complications specific to diabetes, including circulatory, renal, ophthalmic, neurologic, and skin disorders.
Current Activities The following three studies are curently being conducted by MTPPI that examine important health services research and economic issues related to diabetes:
- The Risk of Hypoglycemia Among a Medicaid Population
- The Role of the Endocrinologist in the Care and Outcomes of Persons with Diabetes
- The Economic Consequences of Diabetes in the United States in 1995
Do you have an idea for a research topic? MTPPI is always looking for research topics that can help the community and industry better utilize new medical technologies. Let us know
Publications
Some recent publications prepared by the Institute in this field are:
- Direct and Indirect Cost of Diabetes in the United States in 1992
- Hospitalization and Expenditures for the Treatment of General Medical Conditions among the U.S. Diabetic Population in 1991
- Thamer M, Ray NF, Taylor T. Association between anti-hypertensive use and hypoglycemia: A case-control study of diabetic users of insulin or sulfonylureas. Clinical Therapeutics 1999;21:1387-1400.